| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fistula | 2 | 2023 | 76 | 1.760 |
Why?
|
| Aortic Aneurysm, Abdominal | 20 | 2008 | 384 | 1.310 |
Why?
|
| Aortic Aneurysm, Thoracic | 23 | 2008 | 595 | 1.290 |
Why?
|
| Cerebral Hemorrhage | 3 | 2018 | 183 | 1.040 |
Why?
|
| Aortic Aneurysm | 15 | 2008 | 230 | 1.020 |
Why?
|
| Carotid Stenosis | 3 | 2014 | 176 | 1.000 |
Why?
|
| Blood Vessel Prosthesis Implantation | 18 | 2008 | 705 | 1.000 |
Why?
|
| Limb Salvage | 5 | 2013 | 162 | 1.000 |
Why?
|
| Intracranial Hypotension | 1 | 2023 | 11 | 0.970 |
Why?
|
| Stents | 14 | 2020 | 1096 | 0.950 |
Why?
|
| Jugular Veins | 11 | 2002 | 107 | 0.890 |
Why?
|
| Central Nervous System Vascular Malformations | 1 | 2023 | 20 | 0.880 |
Why?
|
| Endovascular Procedures | 4 | 2020 | 516 | 0.790 |
Why?
|
| Cerebral Angiography | 5 | 2020 | 129 | 0.750 |
Why?
|
| Embolization, Therapeutic | 3 | 2023 | 551 | 0.740 |
Why?
|
| Tunica Intima | 10 | 2009 | 117 | 0.700 |
Why?
|
| Vascular Surgical Procedures | 13 | 2013 | 655 | 0.680 |
Why?
|
| Hematoma | 3 | 2018 | 160 | 0.670 |
Why?
|
| Thrombectomy | 3 | 2008 | 158 | 0.640 |
Why?
|
| Aortic Diseases | 5 | 2013 | 206 | 0.600 |
Why?
|
| Aorta, Thoracic | 9 | 2013 | 546 | 0.540 |
Why?
|
| Venous Thrombosis | 3 | 2008 | 384 | 0.530 |
Why?
|
| Perfusion | 8 | 2005 | 293 | 0.520 |
Why?
|
| Thrombolytic Therapy | 2 | 2008 | 257 | 0.520 |
Why?
|
| Angioplasty, Balloon | 4 | 2009 | 183 | 0.510 |
Why?
|
| Arterial Occlusive Diseases | 2 | 2013 | 160 | 0.500 |
Why?
|
| Endarterectomy | 1 | 2013 | 25 | 0.460 |
Why?
|
| Vascular Grafting | 1 | 2013 | 50 | 0.440 |
Why?
|
| Veins | 5 | 1999 | 157 | 0.430 |
Why?
|
| Lower Extremity | 4 | 2008 | 299 | 0.380 |
Why?
|
| Cerebrospinal Fluid Pressure | 3 | 2005 | 21 | 0.370 |
Why?
|
| Carotid Arteries | 7 | 2001 | 240 | 0.370 |
Why?
|
| Femoral Artery | 3 | 2009 | 210 | 0.360 |
Why?
|
| Rabbits | 16 | 2002 | 957 | 0.360 |
Why?
|
| GTP-Binding Proteins | 5 | 2000 | 321 | 0.360 |
Why?
|
| Peripheral Arterial Disease | 1 | 2013 | 267 | 0.340 |
Why?
|
| Aneurysm, Ruptured | 2 | 2020 | 45 | 0.340 |
Why?
|
| Aneurysm, Dissecting | 4 | 2002 | 4 | 0.340 |
Why?
|
| Hyperplasia | 12 | 2002 | 557 | 0.330 |
Why?
|
| Nervous System Diseases | 5 | 2005 | 500 | 0.320 |
Why?
|
| Hypotension | 2 | 2007 | 210 | 0.320 |
Why?
|
| Intracranial Aneurysm | 2 | 2020 | 123 | 0.320 |
Why?
|
| Popliteal Artery | 2 | 2007 | 52 | 0.310 |
Why?
|
| Bradycardia | 1 | 2007 | 70 | 0.300 |
Why?
|
| Hypothermia, Induced | 4 | 2005 | 170 | 0.300 |
Why?
|
| Paraplegia | 6 | 2007 | 95 | 0.300 |
Why?
|
| Endarterectomy, Carotid | 1 | 2008 | 121 | 0.290 |
Why?
|
| Stroke | 3 | 2014 | 1144 | 0.290 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 1162 | 0.280 |
Why?
|
| Anticoagulants | 5 | 2013 | 787 | 0.280 |
Why?
|
| Paraparesis | 4 | 2005 | 17 | 0.280 |
Why?
|
| Mass Screening | 1 | 2014 | 1509 | 0.270 |
Why?
|
| Central Venous Pressure | 1 | 2005 | 28 | 0.270 |
Why?
|
| Hemodynamics | 6 | 2013 | 935 | 0.270 |
Why?
|
| Severity of Illness Index | 2 | 2015 | 4320 | 0.260 |
Why?
|
| Orthopedic Procedures | 1 | 2006 | 146 | 0.260 |
Why?
|
| Glomerular Filtration Rate | 2 | 2006 | 602 | 0.260 |
Why?
|
| Blood Vessel Prosthesis | 9 | 2008 | 412 | 0.250 |
Why?
|
| Treatment Outcome | 29 | 2020 | 32848 | 0.250 |
Why?
|
| Myelography | 1 | 2023 | 16 | 0.240 |
Why?
|
| Risk Factors | 18 | 2014 | 17523 | 0.240 |
Why?
|
| Humans | 74 | 2023 | 261506 | 0.240 |
Why?
|
| Fibrinolytic Agents | 1 | 2006 | 324 | 0.240 |
Why?
|
| Postoperative Complications | 13 | 2018 | 5542 | 0.240 |
Why?
|
| Creatinine | 2 | 2005 | 531 | 0.240 |
Why?
|
| Acute Kidney Injury | 3 | 2012 | 739 | 0.240 |
Why?
|
| Glasgow Coma Scale | 2 | 2015 | 215 | 0.240 |
Why?
|
| Male | 59 | 2018 | 123000 | 0.240 |
Why?
|
| Cerebrospinal Fluid Leak | 1 | 2023 | 54 | 0.240 |
Why?
|
| Middle Aged | 41 | 2023 | 86204 | 0.230 |
Why?
|
| Female | 52 | 2023 | 141928 | 0.230 |
Why?
|
| Regional Blood Flow | 3 | 2013 | 276 | 0.230 |
Why?
|
| Aorta | 6 | 2014 | 692 | 0.220 |
Why?
|
| Cerebrovascular Circulation | 4 | 2020 | 471 | 0.210 |
Why?
|
| Aortography | 5 | 2008 | 181 | 0.210 |
Why?
|
| Aneurysm, False | 3 | 2008 | 153 | 0.210 |
Why?
|
| Hospitals, University | 1 | 2002 | 209 | 0.200 |
Why?
|
| Aged | 41 | 2018 | 70117 | 0.200 |
Why?
|
| Spinal Cord Ischemia | 5 | 2007 | 27 | 0.200 |
Why?
|
| Tomography, X-Ray Computed | 11 | 2023 | 7551 | 0.200 |
Why?
|
| Extremities | 1 | 2023 | 303 | 0.200 |
Why?
|
| Computed Tomography Angiography | 2 | 2020 | 234 | 0.200 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 1999 | 1756 | 0.190 |
Why?
|
| Circle of Willis | 1 | 2020 | 2 | 0.190 |
Why?
|
| Cardiovascular Agents | 3 | 2013 | 128 | 0.190 |
Why?
|
| Cerebrospinal Fluid | 4 | 2005 | 120 | 0.190 |
Why?
|
| Neuroimaging | 1 | 2023 | 403 | 0.180 |
Why?
|
| Lumbar Vertebrae | 2 | 2014 | 245 | 0.180 |
Why?
|
| Kidney Diseases | 1 | 2005 | 691 | 0.180 |
Why?
|
| Lipid Peroxides | 1 | 1999 | 22 | 0.180 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2008 | 2594 | 0.180 |
Why?
|
| Lipoproteins | 1 | 2001 | 252 | 0.170 |
Why?
|
| Mesenteric Vascular Occlusion | 2 | 2009 | 18 | 0.170 |
Why?
|
| Vasospasm, Intracranial | 1 | 2018 | 22 | 0.170 |
Why?
|
| Biocompatible Materials | 1 | 1999 | 202 | 0.160 |
Why?
|
| Retrospective Studies | 19 | 2023 | 37905 | 0.160 |
Why?
|
| Superoxide Dismutase | 1 | 1999 | 266 | 0.160 |
Why?
|
| Follow-Up Studies | 13 | 2015 | 14889 | 0.160 |
Why?
|
| Drainage | 4 | 2005 | 416 | 0.160 |
Why?
|
| Sex Factors | 2 | 2013 | 2139 | 0.150 |
Why?
|
| Carotid Artery, Common | 5 | 2007 | 91 | 0.150 |
Why?
|
| Feasibility Studies | 1 | 2023 | 2292 | 0.150 |
Why?
|
| Aged, 80 and over | 26 | 2018 | 29902 | 0.150 |
Why?
|
| Survival Analysis | 9 | 2013 | 9180 | 0.150 |
Why?
|
| Prospective Studies | 8 | 2018 | 12873 | 0.150 |
Why?
|
| Saphenous Vein | 2 | 2007 | 95 | 0.140 |
Why?
|
| Length of Stay | 2 | 2009 | 1900 | 0.140 |
Why?
|
| Cohort Studies | 5 | 2018 | 9244 | 0.140 |
Why?
|
| Collagen | 1 | 1999 | 752 | 0.140 |
Why?
|
| Gene Transfer Techniques | 2 | 1998 | 716 | 0.140 |
Why?
|
| Superior Vena Cava Syndrome | 2 | 2007 | 36 | 0.140 |
Why?
|
| Predictive Value of Tests | 5 | 2015 | 4892 | 0.140 |
Why?
|
| Femoral Vein | 2 | 2006 | 66 | 0.130 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 3 | 2005 | 111 | 0.130 |
Why?
|
| Logistic Models | 7 | 2008 | 3441 | 0.130 |
Why?
|
| Vena Cava Filters | 2 | 2014 | 88 | 0.130 |
Why?
|
| Serotonin | 4 | 2006 | 264 | 0.130 |
Why?
|
| Ischemia | 2 | 2009 | 391 | 0.130 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 3 | 2002 | 234 | 0.130 |
Why?
|
| Renal Artery | 2 | 2012 | 79 | 0.130 |
Why?
|
| Time Factors | 13 | 2009 | 12926 | 0.120 |
Why?
|
| Norepinephrine | 3 | 1999 | 272 | 0.120 |
Why?
|
| Vasoconstrictor Agents | 3 | 1999 | 151 | 0.120 |
Why?
|
| Endothelium, Vascular | 6 | 2006 | 891 | 0.110 |
Why?
|
| Foreign-Body Migration | 1 | 2014 | 117 | 0.110 |
Why?
|
| Vasodilation | 2 | 2006 | 205 | 0.110 |
Why?
|
| Survival Rate | 11 | 2007 | 12221 | 0.110 |
Why?
|
| Adenoviridae | 1 | 1998 | 1459 | 0.110 |
Why?
|
| Adult | 27 | 2018 | 77950 | 0.110 |
Why?
|
| Arteries | 1 | 2014 | 274 | 0.110 |
Why?
|
| Angioscopy | 2 | 2009 | 7 | 0.110 |
Why?
|
| Vasoconstriction | 4 | 1999 | 104 | 0.100 |
Why?
|
| Chemoembolization, Therapeutic | 1 | 2013 | 181 | 0.100 |
Why?
|
| Risk Reduction Behavior | 1 | 2013 | 227 | 0.100 |
Why?
|
| Vascular Neoplasms | 1 | 2012 | 114 | 0.100 |
Why?
|
| Area Under Curve | 1 | 2013 | 700 | 0.100 |
Why?
|
| Observer Variation | 1 | 2013 | 671 | 0.100 |
Why?
|
| Virulence Factors, Bordetella | 3 | 1999 | 41 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2023 | 7702 | 0.090 |
Why?
|
| Age Factors | 4 | 2008 | 5377 | 0.090 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2012 | 262 | 0.090 |
Why?
|
| Thromboplastin | 2 | 2001 | 34 | 0.090 |
Why?
|
| Iliac Artery | 2 | 2008 | 108 | 0.090 |
Why?
|
| Comorbidity | 2 | 2007 | 2352 | 0.090 |
Why?
|
| Aortic Rupture | 2 | 2008 | 113 | 0.090 |
Why?
|
| Angioplasty | 2 | 2008 | 94 | 0.090 |
Why?
|
| Aorta, Abdominal | 4 | 2003 | 152 | 0.090 |
Why?
|
| Health Status | 1 | 2013 | 590 | 0.090 |
Why?
|
| Patient Selection | 3 | 2013 | 2055 | 0.090 |
Why?
|
| Blotting, Western | 3 | 2001 | 3536 | 0.090 |
Why?
|
| Regression Analysis | 1 | 2013 | 1546 | 0.090 |
Why?
|
| Gastroepiploic Artery | 1 | 2009 | 5 | 0.090 |
Why?
|
| Peptic Ulcer Hemorrhage | 1 | 2009 | 34 | 0.090 |
Why?
|
| Constriction | 2 | 2005 | 55 | 0.090 |
Why?
|
| Arteriosclerosis | 2 | 1999 | 185 | 0.080 |
Why?
|
| Muscle, Smooth, Vascular | 3 | 1999 | 330 | 0.080 |
Why?
|
| Duodenal Ulcer | 1 | 2009 | 113 | 0.080 |
Why?
|
| Risk | 1 | 2013 | 1972 | 0.080 |
Why?
|
| Laminectomy | 1 | 2008 | 52 | 0.080 |
Why?
|
| Thoracic Injuries | 1 | 2008 | 58 | 0.080 |
Why?
|
| Cholecystostomy | 1 | 2007 | 9 | 0.080 |
Why?
|
| Carotid Artery, Internal, Dissection | 1 | 2007 | 8 | 0.080 |
Why?
|
| Recreation | 1 | 2007 | 22 | 0.080 |
Why?
|
| Cardiopulmonary Bypass | 3 | 2005 | 422 | 0.080 |
Why?
|
| Contrast Media | 1 | 2014 | 1472 | 0.080 |
Why?
|
| Cholecystitis, Acute | 1 | 2007 | 17 | 0.080 |
Why?
|
| Fasciotomy | 1 | 2007 | 43 | 0.080 |
Why?
|
| Catheterization | 2 | 2007 | 410 | 0.080 |
Why?
|
| Mesenteric Arteries | 1 | 2007 | 55 | 0.080 |
Why?
|
| Healthcare Disparities | 1 | 2013 | 598 | 0.070 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2008 | 136 | 0.070 |
Why?
|
| In Vitro Techniques | 2 | 2001 | 1618 | 0.070 |
Why?
|
| Popliteal Vein | 1 | 2006 | 9 | 0.070 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2007 | 60 | 0.070 |
Why?
|
| Adolescent | 14 | 2006 | 31252 | 0.070 |
Why?
|
| Intermediate Filament Proteins | 1 | 2007 | 81 | 0.070 |
Why?
|
| Animals | 17 | 2006 | 59536 | 0.070 |
Why?
|
| Iliac Vein | 1 | 2006 | 38 | 0.070 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2008 | 112 | 0.070 |
Why?
|
| Microscopy, Electron | 4 | 2002 | 600 | 0.070 |
Why?
|
| Iatrogenic Disease | 1 | 2007 | 183 | 0.070 |
Why?
|
| Leg Injuries | 1 | 2006 | 31 | 0.070 |
Why?
|
| Fascia | 1 | 2006 | 68 | 0.070 |
Why?
|
| Vascular Diseases | 1 | 2009 | 246 | 0.070 |
Why?
|
| Angiography | 4 | 2009 | 360 | 0.070 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2013 | 1648 | 0.070 |
Why?
|
| Combined Modality Therapy | 3 | 2013 | 8865 | 0.070 |
Why?
|
| Prosthesis Design | 4 | 2009 | 749 | 0.070 |
Why?
|
| Prognosis | 6 | 2018 | 21713 | 0.070 |
Why?
|
| Graft Survival | 2 | 1999 | 1062 | 0.070 |
Why?
|
| Brachiocephalic Veins | 1 | 2005 | 21 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2006 | 4938 | 0.060 |
Why?
|
| beta-Adrenergic Receptor Kinases | 3 | 2002 | 58 | 0.060 |
Why?
|
| Hospital Mortality | 3 | 2005 | 1274 | 0.060 |
Why?
|
| Coronary Artery Bypass | 2 | 2007 | 708 | 0.060 |
Why?
|
| Cocaine-Related Disorders | 1 | 2007 | 231 | 0.060 |
Why?
|
| Liver Transplantation | 1 | 2013 | 1112 | 0.060 |
Why?
|
| Surgical Procedures, Operative | 1 | 2008 | 383 | 0.060 |
Why?
|
| Reoperation | 5 | 2008 | 1382 | 0.060 |
Why?
|
| Neurologic Examination | 2 | 2001 | 245 | 0.060 |
Why?
|
| Thoracic Neoplasms | 1 | 2007 | 337 | 0.060 |
Why?
|
| Microscopy, Electron, Scanning | 3 | 1999 | 220 | 0.060 |
Why?
|
| Recombinant Proteins | 2 | 2001 | 2927 | 0.060 |
Why?
|
| Bradykinin | 2 | 2006 | 79 | 0.060 |
Why?
|
| CD18 Antigens | 2 | 2001 | 83 | 0.060 |
Why?
|
| Wounds and Injuries | 1 | 2007 | 399 | 0.060 |
Why?
|
| Child | 10 | 2006 | 29154 | 0.060 |
Why?
|
| Signal Transduction | 2 | 1998 | 11965 | 0.060 |
Why?
|
| Monitoring, Intraoperative | 1 | 2005 | 264 | 0.060 |
Why?
|
| Venous Thromboembolism | 1 | 2008 | 335 | 0.060 |
Why?
|
| Intraoperative Period | 2 | 2003 | 246 | 0.060 |
Why?
|
| Biomechanical Phenomena | 2 | 2007 | 338 | 0.060 |
Why?
|
| Receptors, Adrenergic, alpha | 2 | 2000 | 15 | 0.060 |
Why?
|
| Hypercholesterolemia | 3 | 2001 | 259 | 0.060 |
Why?
|
| Pertussis Toxin | 2 | 1999 | 57 | 0.060 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2002 | 40 | 0.050 |
Why?
|
| Vasodilator Agents | 2 | 2006 | 219 | 0.050 |
Why?
|
| Graft Occlusion, Vascular | 2 | 2000 | 118 | 0.050 |
Why?
|
| Heart Atria | 1 | 2005 | 352 | 0.050 |
Why?
|
| Hemoperfusion | 1 | 2001 | 5 | 0.050 |
Why?
|
| Blood Flow Velocity | 2 | 2005 | 475 | 0.050 |
Why?
|
| Sarcoma | 1 | 2012 | 1725 | 0.050 |
Why?
|
| Muscle Relaxation | 1 | 2001 | 19 | 0.050 |
Why?
|
| Dissection | 1 | 2002 | 156 | 0.050 |
Why?
|
| Vascular Patency | 3 | 2009 | 218 | 0.050 |
Why?
|
| Spinal Puncture | 1 | 2001 | 63 | 0.050 |
Why?
|
| Radiography | 3 | 2014 | 1904 | 0.050 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2002 | 198 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 2 | 2009 | 2403 | 0.050 |
Why?
|
| Elective Surgical Procedures | 1 | 2002 | 250 | 0.050 |
Why?
|
| Diaphragm | 1 | 2002 | 181 | 0.050 |
Why?
|
| Renal Dialysis | 1 | 2008 | 945 | 0.050 |
Why?
|
| Posterior Cerebral Artery | 1 | 2020 | 8 | 0.050 |
Why?
|
| Acute Disease | 4 | 2008 | 2422 | 0.050 |
Why?
|
| Endothelial Growth Factors | 1 | 2001 | 197 | 0.050 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2013 | 2027 | 0.050 |
Why?
|
| Lymphokines | 1 | 2001 | 272 | 0.050 |
Why?
|
| Phosphorylation | 2 | 1999 | 4804 | 0.050 |
Why?
|
| Minimally Invasive Surgical Procedures | 3 | 2007 | 500 | 0.050 |
Why?
|
| Research Design | 1 | 2008 | 1544 | 0.050 |
Why?
|
| Muscle, Smooth | 1 | 2001 | 236 | 0.050 |
Why?
|
| Therapies, Investigational | 1 | 2020 | 62 | 0.040 |
Why?
|
| Cholesterol, Dietary | 1 | 1999 | 54 | 0.040 |
Why?
|
| Malondialdehyde | 1 | 1999 | 47 | 0.040 |
Why?
|
| Diet, Fat-Restricted | 1 | 1999 | 56 | 0.040 |
Why?
|
| Transgenes | 2 | 1998 | 557 | 0.040 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2020 | 95 | 0.040 |
Why?
|
| Atherosclerosis | 1 | 2007 | 935 | 0.040 |
Why?
|
| Free Radical Scavengers | 1 | 1999 | 80 | 0.040 |
Why?
|
| Organ Preservation | 1 | 1999 | 43 | 0.040 |
Why?
|
| Tunica Media | 1 | 1999 | 22 | 0.040 |
Why?
|
| Cardiotonic Agents | 1 | 2000 | 151 | 0.040 |
Why?
|
| Coronary Disease | 1 | 2003 | 764 | 0.040 |
Why?
|
| Renal Insufficiency | 1 | 2002 | 321 | 0.040 |
Why?
|
| Linear Models | 1 | 2002 | 1085 | 0.040 |
Why?
|
| Polyethylene Glycols | 2 | 1999 | 615 | 0.040 |
Why?
|
| Potassium Chloride | 1 | 1998 | 55 | 0.040 |
Why?
|
| Tritium | 1 | 1998 | 200 | 0.040 |
Why?
|
| Dopamine | 1 | 2000 | 312 | 0.040 |
Why?
|
| Preoperative Care | 3 | 2013 | 1529 | 0.040 |
Why?
|
| Dimethyl Sulfoxide | 1 | 1998 | 52 | 0.040 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 1998 | 703 | 0.040 |
Why?
|
| Thymidine | 1 | 1998 | 155 | 0.040 |
Why?
|
| Cryopreservation | 1 | 1999 | 175 | 0.040 |
Why?
|
| Cattle | 1 | 1999 | 783 | 0.040 |
Why?
|
| Administration, Topical | 1 | 1998 | 257 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 1999 | 717 | 0.040 |
Why?
|
| Risk Assessment | 5 | 2009 | 6869 | 0.040 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2008 | 216 | 0.040 |
Why?
|
| Tyrosine | 1 | 1998 | 498 | 0.040 |
Why?
|
| Heart | 1 | 2003 | 1223 | 0.040 |
Why?
|
| Leukocytes | 1 | 1998 | 422 | 0.040 |
Why?
|
| Arginine | 1 | 1999 | 500 | 0.030 |
Why?
|
| Liver Neoplasms | 1 | 2013 | 4557 | 0.030 |
Why?
|
| Inflammation | 1 | 2006 | 2522 | 0.030 |
Why?
|
| Texas | 2 | 2009 | 6311 | 0.030 |
Why?
|
| Chronic Disease | 3 | 2009 | 1819 | 0.030 |
Why?
|
| Incidence | 2 | 2005 | 5673 | 0.030 |
Why?
|
| Abdominal Pain | 2 | 2008 | 369 | 0.030 |
Why?
|
| Swine | 1 | 1999 | 1541 | 0.030 |
Why?
|
| Immunohistochemistry | 3 | 2001 | 7548 | 0.030 |
Why?
|
| Dietary Supplements | 1 | 1999 | 558 | 0.030 |
Why?
|
| Intestines | 1 | 1999 | 686 | 0.030 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2009 | 444 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 1998 | 461 | 0.030 |
Why?
|
| Multivariate Analysis | 3 | 2009 | 4298 | 0.030 |
Why?
|
| Actuarial Analysis | 2 | 2004 | 159 | 0.030 |
Why?
|
| Enzyme Inhibitors | 2 | 2000 | 1879 | 0.030 |
Why?
|
| Longitudinal Studies | 2 | 2013 | 1945 | 0.030 |
Why?
|
| Nitriles | 1 | 1998 | 906 | 0.030 |
Why?
|
| Ontario | 1 | 2013 | 98 | 0.030 |
Why?
|
| Anastomosis, Surgical | 2 | 2005 | 371 | 0.030 |
Why?
|
| Heart Arrest, Induced | 2 | 2005 | 87 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 1999 | 1129 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 1998 | 1271 | 0.030 |
Why?
|
| Colorectal Neoplasms | 1 | 2008 | 3578 | 0.030 |
Why?
|
| Catheters, Indwelling | 2 | 2007 | 374 | 0.030 |
Why?
|
| Echocardiography, Transesophageal | 2 | 2004 | 303 | 0.030 |
Why?
|
| Apoptosis | 1 | 2006 | 7591 | 0.030 |
Why?
|
| Europe | 1 | 2013 | 649 | 0.020 |
Why?
|
| Odds Ratio | 2 | 2008 | 2316 | 0.020 |
Why?
|
| Cause of Death | 2 | 2004 | 752 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2013 | 4971 | 0.020 |
Why?
|
| Adrenergic alpha-Antagonists | 2 | 2000 | 67 | 0.020 |
Why?
|
| Brain | 1 | 2003 | 4113 | 0.020 |
Why?
|
| DNA | 1 | 1998 | 2693 | 0.020 |
Why?
|
| Nitric Oxide | 2 | 2006 | 644 | 0.020 |
Why?
|
| Stockings, Compression | 1 | 2008 | 8 | 0.020 |
Why?
|
| Pressure | 1 | 2008 | 215 | 0.020 |
Why?
|
| Intermittent Pneumatic Compression Devices | 1 | 2008 | 11 | 0.020 |
Why?
|
| Awareness | 1 | 2009 | 126 | 0.020 |
Why?
|
| Phlebography | 1 | 2008 | 76 | 0.020 |
Why?
|
| Tibial Arteries | 1 | 2007 | 14 | 0.020 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2007 | 60 | 0.020 |
Why?
|
| Thrombin | 1 | 2008 | 99 | 0.020 |
Why?
|
| Mesenteric Veins | 1 | 2008 | 73 | 0.020 |
Why?
|
| S100 Calcium Binding Protein beta Subunit | 1 | 2007 | 13 | 0.020 |
Why?
|
| Neurofilament Proteins | 1 | 2007 | 30 | 0.020 |
Why?
|
| Survivors | 1 | 2013 | 1031 | 0.020 |
Why?
|
| Calcimycin | 1 | 2006 | 48 | 0.020 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2009 | 257 | 0.020 |
Why?
|
| Polysaccharides | 1 | 2008 | 197 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2003 | 2307 | 0.020 |
Why?
|
| Warfarin | 1 | 2008 | 152 | 0.020 |
Why?
|
| Nerve Growth Factors | 1 | 2007 | 109 | 0.020 |
Why?
|
| Carotid Artery Diseases | 1 | 2008 | 196 | 0.020 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2007 | 151 | 0.020 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2009 | 323 | 0.020 |
Why?
|
| Adenosine Diphosphate | 1 | 2006 | 113 | 0.020 |
Why?
|
| S100 Proteins | 1 | 2007 | 181 | 0.020 |
Why?
|
| Sus scrofa | 1 | 2006 | 169 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2009 | 1323 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2006 | 241 | 0.020 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2006 | 134 | 0.020 |
Why?
|
| Radiography, Interventional | 1 | 2007 | 305 | 0.020 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2008 | 361 | 0.020 |
Why?
|
| Prevalence | 1 | 2013 | 3260 | 0.020 |
Why?
|
| CD3 Complex | 1 | 2006 | 314 | 0.020 |
Why?
|
| Cerebral Arteries | 1 | 2005 | 73 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2009 | 636 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2012 | 3981 | 0.020 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2004 | 53 | 0.020 |
Why?
|
| Models, Animal | 1 | 2006 | 664 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2008 | 1544 | 0.010 |
Why?
|
| Ultrasonography, Interventional | 1 | 2006 | 429 | 0.010 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 2003 | 19 | 0.010 |
Why?
|
| Equipment Design | 1 | 2006 | 1204 | 0.010 |
Why?
|
| Mitogens | 1 | 2002 | 75 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 6009 | 0.010 |
Why?
|
| Chemotaxis | 1 | 2002 | 138 | 0.010 |
Why?
|
| Prosthesis Failure | 1 | 2003 | 206 | 0.010 |
Why?
|
| Health Services Needs and Demand | 1 | 2004 | 244 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 2009 | 918 | 0.010 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2002 | 157 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2008 | 3472 | 0.010 |
Why?
|
| Probability | 1 | 2003 | 866 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2003 | 665 | 0.010 |
Why?
|
| Paralysis | 1 | 2001 | 51 | 0.010 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2009 | 849 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2009 | 1209 | 0.010 |
Why?
|
| Penile Erection | 1 | 2001 | 86 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2007 | 1863 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 2002 | 423 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2006 | 1385 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2001 | 212 | 0.010 |
Why?
|
| Phenoxybenzamine | 1 | 2000 | 10 | 0.010 |
Why?
|
| omega-N-Methylarginine | 1 | 2000 | 34 | 0.010 |
Why?
|
| Emergencies | 1 | 2002 | 202 | 0.010 |
Why?
|
| Recurrence | 1 | 2009 | 4758 | 0.010 |
Why?
|
| Receptors, Dopamine | 1 | 2000 | 42 | 0.010 |
Why?
|
| Cholera Toxin | 1 | 2000 | 63 | 0.010 |
Why?
|
| Prostaglandins | 1 | 2000 | 77 | 0.010 |
Why?
|
| Morbidity | 1 | 2001 | 397 | 0.010 |
Why?
|
| Indomethacin | 1 | 2000 | 91 | 0.010 |
Why?
|
| Penis | 1 | 2001 | 123 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2004 | 703 | 0.010 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2009 | 1303 | 0.010 |
Why?
|
| Suture Techniques | 1 | 2002 | 319 | 0.010 |
Why?
|
| Microscopy, Video | 1 | 1999 | 27 | 0.010 |
Why?
|
| Prazosin | 1 | 1999 | 22 | 0.010 |
Why?
|
| Dioxanes | 1 | 1999 | 11 | 0.010 |
Why?
|
| Phenylephrine | 1 | 1999 | 48 | 0.010 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 1999 | 42 | 0.010 |
Why?
|
| Salvage Therapy | 1 | 2008 | 2054 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1999 | 204 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2009 | 6207 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2009 | 4314 | 0.010 |
Why?
|
| Cell Division | 1 | 2002 | 2489 | 0.010 |
Why?
|
| United States | 2 | 2008 | 15433 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2001 | 1489 | 0.010 |
Why?
|
| Hyperlipidemias | 1 | 1999 | 235 | 0.010 |
Why?
|
| Glutathione | 1 | 1999 | 368 | 0.010 |
Why?
|
| Adjuvants, Immunologic | 1 | 2000 | 657 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 1998 | 980 | 0.010 |
Why?
|
| Antibodies | 1 | 1998 | 838 | 0.010 |
Why?
|
| Biomarkers | 1 | 2007 | 5047 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 2003 | 960 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2003 | 4988 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2001 | 1533 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2002 | 5637 | 0.010 |
Why?
|
| Disease Progression | 1 | 2004 | 6682 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2003 | 6100 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 1999 | 2843 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2000 | 2218 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2004 | 10001 | 0.010 |
Why?
|
| Base Sequence | 1 | 1998 | 4917 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1998 | 6089 | 0.010 |
Why?
|
| Piperazines | 1 | 1999 | 2101 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 14289 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2001 | 7222 | 0.000 |
Why?
|
| Phenotype | 1 | 1998 | 6295 | 0.000 |
Why?
|
| Lung Neoplasms | 1 | 2007 | 11538 | 0.000 |
Why?
|
| Neoplasms | 1 | 2008 | 15193 | 0.000 |
Why?
|
| Mice | 1 | 1998 | 34495 | 0.000 |
Why?
|